# pathway_0047

[All questions and paired results](../README.md) · [Method](../METHOD.md) · [Source credits](../THIRD_PARTY_NOTICES.md)

**Task:** `pathway`  
**Author expected answer:** **D** — Protein modification

| Reviewer | Expected-answer support | Reasoning / lookup | Validity |
|---|---|---|---|
| GPT-6 Luna | supported | lookup-dependent | valid_review |
| Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | valid_review |

**Paired comparison:** key agree; reasoning differ. Agreement is not proof of correctness. These are separate AI judgments, with no forced consensus or changed key.

## Complete original question

```text
[Protein Sequence]
MTALDTDTPTAGRSAPLISPGPVIPPPDFGPLDRAQGWAMTAIITALAAITRFLNLGSPTDAGTPIFDEKHYAPQAWQVLHNDGVEDNPGYGLVVHPPVGKQLIAIGEWLFGYNGLGWRFSGAVCGVIIVMLVTRIARRISRSTLVGAIAGLLIIADGVSFVSSRTALLDVFLVMFAVAAFACLMVDRDQVRERMYHAFLDGRIAETRWGTRLGVRWWRFGAGVLLGLACATKWSGLYFVLFFGVMTLVFDAIARKQYHVPHPWRGMLRRDLGPAAYVFGLIPFAVYLASYAPWFASETAVNRYEVGRSIGPDSILPIPDALRSLWHYTHAAYRFHSNLTNADGNHHPWESKPWTWPMSLRPVLYAIDNQDVPGCGAQSCVKAVMLVGTPAMWFIAVPVLGWALWRTVVRRDWRYGAVLVGYMAGFLPWFADIDRQMYFFYATVMAPFLVLAIALILGDILYKPNQNPERRTLGLLTVCFYVALVITNFAWMYPILTGLPISQTTWNLQIWLPSWR

[Multiple Choices]
A. IMP biosynthesis via de novo pathway
B. ubiquinone biosynthesis. .
C. L-cystathionine from O-succinyl-L-homoserine: step 1/1. .
D. Protein modification
```

<details>
<summary>Original system instructions, verbatim</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Protein Pathway Prediction, which is to predict the primary metabolic or signaling pathway in which a given protein functions. Biological pathways are series of chemical reactions occurring within a cell that are essential for life. Based on the protein's amino acid sequence, you should identify the most relevant pathway from the given options.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## GPT-6 Luna

**Saved status:** `valid_review`.

### Expected-answer support: supported

> The supplied sequence exactly matches the UniProt record for a polyprenol-phosphate-mannose–protein mannosyltransferase, whose pathway annotation is “Protein modification; protein glycosylation.” The annotation carries an experimental evidence code and cites a publication, although the underlying experiments were not independently reviewed here.

Citations as saved: [C1](#evidence-c1), [C4](#evidence-c4), [C5](#evidence-c5), [H3](#evidence-h3).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence’s many hydrophobic regions support that it is a membrane protein, but that general feature does not establish that it modifies proteins by mannosylation or distinguish that function from other membrane-protein functions.


**Missing item-specific fact**

> The protein-specific functional annotation identifying this sequence as a protein O-mannosyltransferase and assigning it to protein modification/protein glycosylation.


**Reason**

> The expected choice is supported by the matched protein annotation, but the sequence and choices alone do not provide a sufficiently specific biological argument for its pathway.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> Among the choices, protein modification is the one consistent with the matched protein’s pathway annotation; the other options name distinct metabolic processes.


### Important caveats

- Reviewer-only accession and database evidence were not supplied to the evaluated model.
- The sequence match establishes source applicability, but the database annotation and its cited experimental evidence are not a substitute for independent evaluation of the primary study.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence’s many hydrophobic regions support that it is a membrane protein, but that general feature does not establish that it modifies proteins by mannosylation or distinguish that function from other membrane-protein functions.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The protein-specific functional annotation identifying this sequence as a protein O-mannosyltransferase and assigning it to protein modification/protein glycosylation.",
    "reason": "The expected choice is supported by the matched protein annotation, but the sequence and choices alone do not provide a sufficiently specific biological argument for its pathway."
  },
  "case_id": "pathway_0047",
  "expected_answer_check": {
    "evidence_ids": [
      "C1",
      "C4",
      "C5",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The supplied sequence exactly matches the UniProt record for a polyprenol-phosphate-mannose–protein mannosyltransferase, whose pathway annotation is “Protein modification; protein glycosylation.” The annotation carries an experimental evidence code and cites a publication, although the underlying experiments were not independently reviewed here."
  },
  "important_caveats": [
    "Reviewer-only accession and database evidence were not supplied to the evaluated model.",
    "The sequence match establishes source applicability, but the database annotation and its cited experimental evidence are not a substitute for independent evaluation of the primary study."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Among the choices, protein modification is the one consistent with the matched protein’s pathway annotation; the other options name distinct metabolic processes."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0047",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The supplied sequence exactly matches the UniProt record for a polyprenol-phosphate-mannose–protein mannosyltransferase, whose pathway annotation is “Protein modification; protein glycosylation.” The annotation carries an experimental evidence code and cites a publication, although the underlying experiments were not independently reviewed here.",
    "evidence_ids": ["C1", "C4", "C5", "H3"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence’s many hydrophobic regions support that it is a membrane protein, but that general feature does not establish that it modifies proteins by mannosylation or distinguish that function from other membrane-protein functions.",
    "missing_item_specific_fact": "The protein-specific functional annotation identifying this sequence as a protein O-mannosyltransferase and assigning it to protein modification/protein glycosylation.",
    "reason": "The expected choice is supported by the matched protein annotation, but the sequence and choices alone do not provide a sufficiently specific biological argument for its pathway."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Among the choices, protein modification is the one consistent with the matched protein’s pathway annotation; the other options name distinct metabolic processes."
  },
  "important_caveats": [
    "Reviewer-only accession and database evidence were not supplied to the evaluated model.",
    "The sequence match establishes source applicability, but the database annotation and its cited experimental evidence are not a substitute for independent evaluation of the primary study."
  ]
}
```

</details>

## Qwen3.8-Flash-Next-NVFP4

**Saved status:** `valid_review`.

### Expected-answer support: supported

> The UniProt entry A0R3E8 (sequence matched, 516 AA) annotates the protein as Polyprenol-phosphate-mannose--protein mannosyltransferase (PMT, EC 2.4.1.-) with pathway 'Protein modification; protein glycosylation' backed by experimental evidence (ECO:0000269, PubMed:23550160, PNAS 2013). The expected answer 'Protein modification' directly matches the UniProt pathway annotation.

Citations as saved: [C4](#evidence-c4), [C5](#evidence-c5), [C6](#evidence-c6), [H1](#evidence-h1), [H3](#evidence-h3).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The sequence contains approximately 8-10 long hydrophobic stretches consistent with a multi-pass transmembrane architecture. This immediately disfavors options A (IMP de novo biosynthesis, catalyzed by soluble enzymes such as PurA/PurB/PurC) and C (a single-step reaction catalyzed by a soluble cystathionine gamma-synthase-type enzyme). Between B (ubiquinone biosynthesis) and D (protein modification), the multi-pass membrane topology with polar/catalytic loops is characteristic of membrane-anchored glycosyltransferases that transfer sugar moieties from a lipid carrier (polyprenol-phosphate-mannose) to protein substrates, a well-documented class in Actinobacteria including Mycobacterium/Mycolicibacterium. Ubiquinone biosynthesis steps (e.g., UbiA prenyltransferase) involve fewer TM segments and different topology. Thus the membrane architecture provides a meaningful, if not fully definitive, biological argument favoring protein modification over the other three choices.


**Missing item-specific fact**

> Precise identification of the mannosyltransferase catalytic motif (e.g., the DxD motif or polyprenol-phosphate-mannose binding region) would confirm the assignment, but the broad membrane-topology argument is sufficient to distinguish among the four provided options.


**Reason**

> A general biologist can eliminate A and C on the basis that those pathways are catalyzed by soluble enzymes, and can note that the extensive multi-pass membrane architecture in an Actinobacterium is more consistent with a membrane-bound glycosyltransferase (protein modification/glycosylation) than with ubiquinone biosynthesis. The reasoning is not trivial but is grounded in general membrane-protein biology and pathway architecture.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> Options A and C are clearly inconsistent with a multi-pass membrane protein. Option B (ubiquinone biosynthesis) is the closest distractor but involves enzymes with different topology and fewer TM domains. The broad category 'Protein modification' encompasses membrane-bound glycosyltransferases and is the most defensible answer given the sequence features.


### Important caveats

- The UniProt annotation is supported by experimental evidence (PubMed:23550160), not solely computational inference, strengthening the expected answer.
- The reasoning argument (multi-pass membrane → glycosyltransferase) is suggestive but not a unique fingerprint; definitive identification of PMT requires recognizing specific catalytic motifs or database lookup.
- The option 'Protein modification' is very broad and encompasses many sub-pathways; the question relies on it being the only option that fits a membrane-bound glycosyltransferase.
- Reviewer-only evidence (UniProt accession, annotation) was not available to the evaluated model; the assessment of reasoning support is based solely on what a knowledgeable biologist could infer from the sequence and choices.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence contains approximately 8-10 long hydrophobic stretches consistent with a multi-pass transmembrane architecture. This immediately disfavors options A (IMP de novo biosynthesis, catalyzed by soluble enzymes such as PurA/PurB/PurC) and C (a single-step reaction catalyzed by a soluble cystathionine gamma-synthase-type enzyme). Between B (ubiquinone biosynthesis) and D (protein modification), the multi-pass membrane topology with polar/catalytic loops is characteristic of membrane-anchored glycosyltransferases that transfer sugar moieties from a lipid carrier (polyprenol-phosphate-mannose) to protein substrates, a well-documented class in Actinobacteria including Mycobacterium/Mycolicibacterium. Ubiquinone biosynthesis steps (e.g., UbiA prenyltransferase) involve fewer TM segments and different topology. Thus the membrane architecture provides a meaningful, if not fully definitive, biological argument favoring protein modification over the other three choices.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "Precise identification of the mannosyltransferase catalytic motif (e.g., the DxD motif or polyprenol-phosphate-mannose binding region) would confirm the assignment, but the broad membrane-topology argument is sufficient to distinguish among the four provided options.",
    "reason": "A general biologist can eliminate A and C on the basis that those pathways are catalyzed by soluble enzymes, and can note that the extensive multi-pass membrane architecture in an Actinobacterium is more consistent with a membrane-bound glycosyltransferase (protein modification/glycosylation) than with ubiquinone biosynthesis. The reasoning is not trivial but is grounded in general membrane-protein biology and pathway architecture."
  },
  "case_id": "pathway_0047",
  "expected_answer_check": {
    "evidence_ids": [
      "C4",
      "C5",
      "C6",
      "H1",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The UniProt entry A0R3E8 (sequence matched, 516 AA) annotates the protein as Polyprenol-phosphate-mannose--protein mannosyltransferase (PMT, EC 2.4.1.-) with pathway 'Protein modification; protein glycosylation' backed by experimental evidence (ECO:0000269, PubMed:23550160, PNAS 2013). The expected answer 'Protein modification' directly matches the UniProt pathway annotation."
  },
  "important_caveats": [
    "The UniProt annotation is supported by experimental evidence (PubMed:23550160), not solely computational inference, strengthening the expected answer.",
    "The reasoning argument (multi-pass membrane → glycosyltransferase) is suggestive but not a unique fingerprint; definitive identification of PMT requires recognizing specific catalytic motifs or database lookup.",
    "The option 'Protein modification' is very broad and encompasses many sub-pathways; the question relies on it being the only option that fits a membrane-bound glycosyltransferase.",
    "Reviewer-only evidence (UniProt accession, annotation) was not available to the evaluated model; the assessment of reasoning support is based solely on what a knowledgeable biologist could infer from the sequence and choices."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Options A and C are clearly inconsistent with a multi-pass membrane protein. Option B (ubiquinone biosynthesis) is the closest distractor but involves enzymes with different topology and fewer TM domains. The broad category 'Protein modification' encompasses membrane-bound glycosyltransferases and is the most defensible answer given the sequence features."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "pathway_0047",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The UniProt entry A0R3E8 (sequence matched, 516 AA) annotates the protein as Polyprenol-phosphate-mannose--protein mannosyltransferase (PMT, EC 2.4.1.-) with pathway 'Protein modification; protein glycosylation' backed by experimental evidence (ECO:0000269, PubMed:23550160, PNAS 2013). The expected answer 'Protein modification' directly matches the UniProt pathway annotation.",
    "evidence_ids": ["C4", "C5", "C6", "H1", "H3"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The sequence contains approximately 8-10 long hydrophobic stretches consistent with a multi-pass transmembrane architecture. This immediately disfavors options A (IMP de novo biosynthesis, catalyzed by soluble enzymes such as PurA/PurB/PurC) and C (a single-step reaction catalyzed by a soluble cystathionine gamma-synthase-type enzyme). Between B (ubiquinone biosynthesis) and D (protein modification), the multi-pass membrane topology with polar/catalytic loops is characteristic of membrane-anchored glycosyltransferases that transfer sugar moieties from a lipid carrier (polyprenol-phosphate-mannose) to protein substrates, a well-documented class in Actinobacteria including Mycobacterium/Mycolicibacterium. Ubiquinone biosynthesis steps (e.g., UbiA prenyltransferase) involve fewer TM segments and different topology. Thus the membrane architecture provides a meaningful, if not fully definitive, biological argument favoring protein modification over the other three choices.",
    "missing_item_specific_fact": "Precise identification of the mannosyltransferase catalytic motif (e.g., the DxD motif or polyprenol-phosphate-mannose binding region) would confirm the assignment, but the broad membrane-topology argument is sufficient to distinguish among the four provided options.",
    "reason": "A general biologist can eliminate A and C on the basis that those pathways are catalyzed by soluble enzymes, and can note that the extensive multi-pass membrane architecture in an Actinobacterium is more consistent with a membrane-bound glycosyltransferase (protein modification/glycosylation) than with ubiquinone biosynthesis. The reasoning is not trivial but is grounded in general membrane-protein biology and pathway architecture."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Options A and C are clearly inconsistent with a multi-pass membrane protein. Option B (ubiquinone biosynthesis) is the closest distractor but involves enzymes with different topology and fewer TM domains. The broad category 'Protein modification' encompasses membrane-bound glycosyltransferases and is the most defensible answer given the sequence features."
  },
  "important_caveats": [
    "The UniProt annotation is supported by experimental evidence (PubMed:23550160), not solely computational inference, strengthening the expected answer.",
    "The reasoning argument (multi-pass membrane → glycosyltransferase) is suggestive but not a unique fingerprint; definitive identification of PMT requires recognizing specific catalytic motifs or database lookup.",
    "The option 'Protein modification' is very broad and encompasses many sub-pathways; the question relies on it being the only option that fits a membrane-bound glycosyltransferase.",
    "Reviewer-only evidence (UniProt accession, annotation) was not available to the evaluated model; the assessment of reasoning support is based solely on what a knowledgeable biologist could infer from the sequence and choices."
  ]
}
```

</details>

## Existing project source checks of Luna’s review

The notes below were prepared for specific claims in the Luna review. They are not independent validation of Qwen’s claims, expert adjudication, or replacement verdicts.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Reviewer-only source evidence

**Both reviewers received this source evidence separately from the original question. It was not available to the original evaluated model.** Source support and reasoning from the original sequence/choices are distinct assessments.

**Accession:** `A0R3E8` (recovered from dataset image-path metadata, not original question text).  
**Sequence applicability:** historical matched; current matched.  
**Historical cutoff:** 2026-05-07; archived entry version 114. Exact author snapshot unknown.

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0R3E8.json)  
**Locator:** `/primaryAccession`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:26:45.822179+00:00.  

```json
"A0R3E8"
```

Source SHA-256: `7460bfadb65f50b4073bc118af38399e6b1513a5f5a97e209de8bb6435c7ac44`.

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0R3E8.json)  
**Locator:** `/proteinDescription`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:26:45.822179+00:00.  

```json
{"alternativeNames":[{"fullName":{"evidences":[{"evidenceCode":"ECO:0000303","id":"23550160","source":"PubMed"}],"value":"Protein O-mannosyltransferase"},"shortNames":[{"evidences":[{"evidenceCode":"ECO:0000303","id":"23550160","source":"PubMed"}],"value":"PMT"}]}],"recommendedName":{"ecNumbers":[{"evidences":[{"evidenceCode":"ECO:0000305","id":"23550160","source":"PubMed"}],"value":"2.4.1.-"}],"fullName":{"evidences":[{"evidenceCode":"ECO:0000305"}],"value":"Polyprenol-phosphate-mannose--protein mannosyltransferase"}}}
```

Source SHA-256: `7460bfadb65f50b4073bc118af38399e6b1513a5f5a97e209de8bb6435c7ac44`.

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0R3E8.json)  
**Locator:** `/comments/1`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:26:45.822179+00:00.  

```json
{"commentType":"PATHWAY","texts":[{"evidences":[{"evidenceCode":"ECO:0000269","id":"23550160","source":"PubMed"}],"value":"Protein modification; protein glycosylation"}]}
```

Source SHA-256: `7460bfadb65f50b4073bc118af38399e6b1513a5f5a97e209de8bb6435c7ac44`.

### Evidence C6

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0R3E8.json)  
**Locator:** `/references/3`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:26:45.822179+00:00.  

```json
{"citation":{"authors":["Liu C.F.","Tonini L.","Malaga W.","Beau M.","Stella A.","Bouyssie D.","Jackson M.C.","Nigou J.","Puzo G.","Guilhot C.","Burlet-Schiltz O.","Riviere M."],"citationCrossReferences":[{"database":"PubMed","id":"23550160"},{"database":"DOI","id":"10.1073/pnas.1219704110"}],"citationType":"journal article","firstPage":"6560","id":"23550160","journal":"Proc. Natl. Acad. Sci. U.S.A.","lastPage":"6565","publicationDate":"2013","title":"Bacterial protein-O-mannosylating enzyme is crucial for virulence of Mycobacterium tuberculosis.","volume":"110"},"referenceComments":[{"type":"STRAIN","value":"ATCC 700084 / mc(2)155"}],"referenceNumber":4,"referencePositions":["FUNCTION","PATHWAY","DISRUPTION PHENOTYPE"]}
```

Source SHA-256: `7460bfadb65f50b4073bc118af38399e6b1513a5f5a97e209de8bb6435c7ac44`.

### Evidence H1

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0R3E8?format=txt&versions=114)  
**Locator:** `lines 1-16`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 114 / 1.  
**Retrieved:** 2026-11-02T04:26:48.840229+00:00.  

```text
ID   PMT_MYCS2               Reviewed;         516 AA.
AC   A0R3E8; I7GFC3;
DT   18-JUN-2025, integrated into UniProtKB/Swiss-Prot.
DT   09-JAN-2007, sequence version 1.
DT   28-JAN-2026, entry version 114.
DE   RecName: Full=Polyprenol-phosphate-mannose--protein mannosyltransferase {ECO:0000305};
DE            EC=2.4.1.- {ECO:0000305|PubMed:23550160};
DE   AltName: Full=Protein O-mannosyltransferase {ECO:0000303|PubMed:23550160};
DE            Short=PMT {ECO:0000303|PubMed:23550160};
GN   OrderedLocusNames=MSMEG_5447 {ECO:0000312|EMBL:ABK72177.1},
GN   MSMEI_5297 {ECO:0000312|EMBL:AFP41739.1};
OS   Mycolicibacterium smegmatis (strain ATCC 700084 / mc(2)155) (Mycobacterium
OS   smegmatis).
OC   Bacteria; Bacillati; Actinomycetota; Actinomycetes; Mycobacteriales;
OC   Mycobacteriaceae; Mycolicibacterium.
OX   NCBI_TaxID=246196;
```

Source SHA-256: `4c32d7463b098ec708cba16ef0ffc8465a4a08c5c9abc6fb7d70933bd38435a7`.

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0R3E8?format=txt&versions=114)  
**Locator:** `lines 54-55`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 114 / 1.  
**Retrieved:** 2026-11-02T04:26:48.840229+00:00.  

```text
CC   -!- PATHWAY: Protein modification; protein glycosylation.
CC       {ECO:0000269|PubMed:23550160}.
```

Source SHA-256: `4c32d7463b098ec708cba16ef0ffc8465a4a08c5c9abc6fb7d70933bd38435a7`.

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/pathway.json), zero-based source row 47. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). UniProt and Gene Ontology credits are retained in [source notices](../THIRD_PARTY_NOTICES.md).
